The Mitogen Activated Protein Kinase Pathway Facilitates Resistance to the Src Inhibitor, Dasatinib, in Thyroid Cancer
Beadnell, T. C., Mishall, K. M., Zhou, Q., Riffert, S. M., Wuensch, K. E., Kessler, B. E., Corpuz, M. L., Jing, X., Kim, J., Wang, G., Tan, A. C., Schweppe, R. E.Language:
english
Journal:
Molecular Cancer Therapeutics
DOI:
10.1158/1535-7163.MCT-15-0702
Date:
May, 2016
File:
PDF, 2.08 MB
english, 2016